Navigation Links
Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
Date:11/3/2010

#160;Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents both administered by IV bolus, the first being a potent highly selective Factor IXa inhibitor (pegnivacogin, a.k.a. RB006) and the second being its complementary active control agent (anivamersen, a.k.a. RB007).  Anivamersen can be used to selectively completely or partially reverse the anticoagulant effect of pegnivacogin.  REG1, presently in a phase 2b clinical trial (the RADAR trial), is intended for application in arterial thrombosis applications, initially in Acute Coronary Syndrome patients intended for Percutaneous Coronary Intervention.  A clinical program in Open Heart Surgery [including coronary artery bypass grafting (CABG) and valve repair/replacement] is also under development.  REG2, Regado's second product candidate, consists of a subcutaneously administered depot formulation of pegnivacogin paired with the IV bolus formulation of anivamersen.  REG2 recently completed single escalating dose phase 1 clinical testing (the first successful subcutaneous application of an aptamer in humans) and is planned to be studied in a multiple escalating dose clinical trial in 2011.  It is intended for use in venous thrombosis indications such as venous thromboembolism (VTE) prophylaxis in patients undergoing abdominal surgery.  REG3, Regado's third program, consists of a specific GPVI inhibitor and its active control agent (RB571 and RB515, respectively).  REG3 is planned to enter phase 1 human clinical testing in 2011 and will be indicated for antiplatelet therapy.  Information pertaining to Regado's clinical programs may be obtained at www.clinicaltrials.gov.

ABOUT APTAMERSPegnivacogin is a member of a class of compounds called aptamers.  Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
2. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
3. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
4. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
5. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
6. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
10. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Corporation (NYSE: EW ), the global leader in ... reported net income for the quarter ended June 30, 2015 ... net income on a non-GAAP basis was $124.4 million, ... diluted share in the prior year period. In the ... diluted share, which included a $750 million payment to ...
(Date:7/28/2015)... Calif. , July 28, 2015   Regulus ... company leading the discovery and development of innovative medicines ... results and highlights for the quarter ended June 30, ... financial markets close. Regulus will host ... 2015, at 5:00 pm Eastern Daylight Time to discuss ...
(Date:7/28/2015)... Holding Company (Nasdaq: ESRX ) announced 2015 second ... $600.1 million, or $0.88 per diluted share.  Adjusted earnings ... $1.44 for the second quarter. 1  ... validating the need for size and scale," said George ... most is how that size and scale is leveraged. ...
Breaking Medicine Technology:Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12
... Inc. (NASDAQ: SUPG ), a pharmaceutical company ... therapies, today announced their June 2nd RetailInvestorConferences.com presentation is ... www.retailinvestorconferences.com > Click the red "register/ watch event ... 24/7 for 90 days. Investors may download shareholder materials ...
... (Nasdaq: ESRX ) announced that it will present ... 16, 2011 at 11:20 a.m. central (12:20 p.m. eastern) at ... presentation will also be broadcast via the Internet and can ... web site at http://www.express-scripts.com  RealPlayer or Windows Media ...
Cached Medicine Technology:SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique women’s wellness ... their healthy and mindful living practices to the next level, announced today an influential ... with Intent as keynote. Global Girls, an Orange County based non-profit that works ...
(Date:7/28/2015)... Port Richey, FL (PRWEB) , ... July 28, ... ... Brown University and The Miriam Hospital examines outcomes for inmates who continued methadone ... found the latter group was more likely to relapse to opiate use (1) ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl Worley’s Annual Tennessee ... the 14th year of raising money for the Darryl Worley Foundation. Worley will ... year’s main concert Saturday, Oct. 3. , This year’s concert will have a ...
(Date:7/28/2015)... ... July 28, 2015 , ... By 2016, the number of smartphones ... engage with customers on a highly personal basis, increasing customer loyalty. However, capitalizing on ... growth opportunities or lose customers to more nimble competitors. , The Open Mobile Summit ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham and Buckingham ... Roy in July 2016. Coming to Austin from Philadelphia, Dr. Roy will be ... twelve-month long training is facilitated annually by the American Academy of Facial Plastic and ...
Breaking Medicine News(10 mins):Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3
... Dr. Calvin B. Johnson today advised consumers who ... Telford, Montgomery County, to,immediately discard the raw milk ... due,to potential bacterial contamination. Raw milk is milk ... consumed raw milk purchased from the dairy,were found ...
... 2008) -- Nearly 100 of the world,s leading authorities on ... sectors will gather in New York City next week to ... treatment of Type 2 Diabetes. Currently, the condition is one ... 23.6 million people in the United States in 2007 alone, ...
... is scar hidden under the bra line, expert says, , , ... bumps and bulges above and below the back of their ... a plastic surgeon in North Carolina has designed a procedure ... In a one-hour procedure, with the patient under general anesthesia, ...
... Benjamin M. Cutler,Chairman and Chief Executive Officer ... insurer providing affordable coverage to small,business owners and ... plans culturally adapted for the Hispanic market in ... healthcare coverages and options for,cost-conscious consumers. The two ...
... Keep His ,State of the State, Promise to ... Sept. 12 New legislation,awaiting Governor Schwarzenegger,s signature ... -- is needed to protect Californians,from future cancellations ... coverage,the most, said Consumer Watchdog., Today,s settlement ...
... 12 In the wake of the President,s,declaration ... of Emergency,prescription history service) has been activated to ... evacuees with private,secure online access to available medication ... information, health care professionals will be able to,effectively ...
Cached Medicine News:Health News:Health and Agriculture Departments Warn Consumers About Raw Milk Sold in Montgomery County 2Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 2Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 3Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 4Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 5Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 6Health News:Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes 7Health News:Bye, Bye Back Fat? 2Health News:Bye, Bye Back Fat? 3Health News:USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida 2Health News:Insurance Cancellation Settlements Not Enough to Protect CA Patients 2
... 420 CPAP System is the smallest and ... on the market. It is designed to ... lifestyles while complying with therapy. The GoodKnight ... of date/time usage data. It also detects ...
Chase micro-hemocrit tubes are manufactured from soda lime glass, packed in plastic vials with reclosable snap-lock caps to maintain cleanliness....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... plastic-coated micro-hematocrit capillary tubes help protect healthcare ... the most common medical procedures. Each BD ... of mylar so thin that it does ... user's visual inspection of the sample. The ...
Medicine Products: